FindTrial
Sign In

Clinical study of splenic artery embolization for the improvement of sarcopenia in cirrhotic hypersplenesenic patients

Clinical study of splenic artery embolization for the improvement of sarcopenia in cirrhotic hypersplenesenic patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064761
Enrollment
Unknown
Registered
2022-10-17
Start date
2022-10-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partial splenic embolism

Interventions

case series:None

Sponsors

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients undergoing initial partial splenic artery embolization.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors; 2. Patients with pancreatic portal hypertension; 3. Patients with splenic aneurysm; 4. Patients with poor control of diabetes; 5. Patients with severe infections; 6. Patients without complete case information.

Design outcomes

Primary

MeasureTime frame
Computed Tomography;Liver function;Blood coagulation function;blood routine;Height;Weight;—

Secondary

MeasureTime frame
Magnetic Resonance Imaging;—

Countries

China

Contacts

Public ContactYuhu Song

Tongji Medical College of Huazhong University of Science and Technology

yuhusong@163.com+86 15007187581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026